People typically lost at least 20% of their body weight after a year of treatment
Two phase 3 trials BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) and BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) evaluated obese and overweight patients to demonstrate the efficacy of lorcaserin (10 mg twice daily) over placebo [83.84]
Batchspecific documentation ensures full traceability for your laboratory records
Long-term benefits (8-12 weeks and beyond) could include cardiovascular improvements, reduced scarring after injuries, and better gastrointestinal health, among other things
Signs You Might Benefit from GLP-1 Treatment BMI of 30+ (or 27+ with weight-related health conditions) History of weight loss attempts without lasting success Weight-related health issues like high blood pressure or prediabetes Difficulty controlling appetite or food cravings Need for structured, medically-guided weight loss approach The GLP-1 Treatment Journey GLP-1 medications are administered as simple subcutaneous injections, typically in the abdomen or thigh
The multi-dose vials and single-patient-use KwikPen each contain 4 doses: 4